“spark-therapeutics” Archives

in
Entry Author Date Location
Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies 10/14/20 Boston
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
MeiraGTx, J&J See Phase 3 Test Ahead for Vision Loss Gene Therapy 07/17/20 New York
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
FTC Challenges PacBio Acquisition, Says Illumina is a “Monopolist” 12/18/19 San Diego
Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer 12/03/19 National
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
UK Regulator Has “Competition Concerns” Over Illumina-PacBio Tie-Up 10/25/19 San Diego
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
As Sangamo Touts Data, BioMarin Preps Hemophilia Gene Therapy For FDA 07/08/19 San Francisco
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
What’s Hot in Boston Biotech 2019: The Photos 06/04/19 Boston
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Register Today and Save on “What’s Hot in Boston Biotech” on May 21 05/10/19 Boston
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon 04/15/19 New York
AskBio Reels In $235M to Advance Gene Therapy Clinical Trials 04/11/19 Raleigh Durham
Thermo Bags Brammer For $1.7B as Gene Therapy Deal Spree Continues 03/25/19 Boston
Pfizer Bolsters Gene Therapy Position with $51M Vivet Deal 03/20/19 New York
Gene Therapy Boom, Cracking Alzheimer’s: What’s Hot on May 21 03/14/19 Boston
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy 02/25/19 National
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy 01/31/19 New York
Can Pay-For-Results Drug Pricing Work? A Q&A With Michael Sherman 12/19/18 Boston
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Page 1 of 4 next page »